FIELD: chemistry.SUBSTANCE: invention relates to compounds of formula 1 , where X and T are N or C, Q is a (3-7)-member aromatic ring which contains 0-3 nitrogen atoms as ring members, and which is optionally benzo-condensed and is substituted with oxo； C1-C6-alkyl； halogen- C1-C6-alkyl； hydroxy-C1-C6-alkyl； C1-C6-alkoxy； C6-C10-aryl； or a (3-7)-member heteroaryl containing 1-3 oxygen atoms, P is C1-C6-alkyl, optionally substituted with a halogen, and R is a group selected from: (i) -C1-C6-alkyl-R1, (ii) -NR2R3, (iii) -O-R4, (iv) -S-R5, (v) -C (=O))-R6, (vi) optionally substituted (3-7)-member heteroaryl containing 1-4 heteroatoms selected from a nitrogen atom, an oxygen atom and a sulphur atom, (vi) optionally substituted (3-7)-member heteroatom containing 1-4 heteroatoms selected from a nitrogen atom, an oxygen atom and a sulphur atom, (vii) optionally substituted, saturated or partially unsaturated, separate or condensed (3-10)-member heterocyclic ring containing 1-4 heteroatoms selected from a nitrogen atom, an oxygen atom and a sulphur atom, (viii) azido； where each R1, R2, R3, R4, R3, R6, is as described in the claim. The invention also relates to a pharmaceutical composition for preventing and treating a vascular disease, which contains a compound of formula 1.EFFECT: compounds of formula 1 with inhibitory activity with reference to aggregation of thrombocytes.7 cl, 7 dwg, 2 tbl, 519 exИзобретение относится к соединениям формулы 1, где X и Т представляют собой N или С, Q представляет собой (3-7)-членный ароматический цикл, который содержит от О до 3 атомов азота в качестве членов цикла, и который необязательно бензоконденсирован, и замещен оксо； C1-С6-алкилом； галоген-С1-С6-алкилом； гидрокси-С1-С6-алкилом； C1-С6-алкокси； С6-С10-арилом； или (3-7)-членным гетероарилом, содержащим от 1 до 3 атомов кислорода, Р представляет собой С1-С6-алкил, необязательно замещенный галогеном, и R представляет собой группу, выбранную из: (i) - С1-С6-алкил-R1, (ii) -NR2R3, (iii
